STIs Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about STIs clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 3

Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia

Pneumocystis PneumoniaPneumocystisPneumocystis Jirovecii Infection+5 more
Todd C. Lee MD MPH FIDSA416 enrolled1 locationNCT04851015
Recruiting
Phase 2

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center50 enrolled7 locationsNCT06736613
Recruiting
Phase 1Phase 2

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Breast CancerEsophageal CancerGastric Cancer+13 more
Tanabe Pharma America, Inc.27 enrolled6 locationsNCT06943521
Recruiting
Phase 3

STI Testing to Enhance PrEP Use in Pregnancy

PregnancySexually Transmitted Infections (STIs)PrEP Adherence
Botswana Harvard AIDS Institute Partnership600 enrolled1 locationNCT06919614
Recruiting
Phase 2

Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults

Pneumocystis Pneumonia
Mundipharma Research Limited50 enrolled6 locationsNCT05835479
Recruiting

Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

HIVSexually Transmitted Infections (STIs)PrEP
Hospital Universitario de Valme9,000 enrolled26 locationsNCT06860945
Recruiting

The South-East Asian Transgender Health Cohort

HIVHCVSTIs
Institute of HIV Research and Innovation Foundation, Thailand450 enrolled5 locationsNCT05454579
Recruiting
Not Applicable

The Effect of Using Multimedia During the Informed Consent Process on the Anxiety of Parents of Orchiopexy Patients

Anxiety StateUndescended Testis
Marmara University70 enrolled1 locationNCT06698081
Recruiting

Caspofungin for Pneumocystis Pneumonia in PLWHIV.

HIV-1-infectionPneumocystis Pneumonia
Instituto Nacional de Enfermedades Respiratorias60 enrolled1 locationNCT06691321
Recruiting
Phase 1

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Endometrial Cancer RecurrentStage IV Ovarian CancerTestis Cancer, Refractory+1 more
Second Affiliated Hospital of Guangzhou Medical University200 enrolled1 locationNCT05410717
Recruiting
Not Applicable

The Man Van Project

Prostate CancerUrologic CancerBladder Cancer+8 more
Royal Marsden NHS Foundation Trust4,000 enrolled1 locationNCT06357416